156 related articles for article (PubMed ID: 38578380)
1. The quality of life impact of the COVID-19 pandemic and lockdowns for people living with multiple sclerosis (MS): evidence from the Australian MS Longitudinal Study.
Henson GJ; van der Mei I; Taylor BV; Blacklow P; Claflin SB; Palmer AJ; Hurst C; Campbell JA
Qual Life Res; 2024 Jun; 33(6):1675-1689. PubMed ID: 38578380
[TBL] [Abstract][Full Text] [Related]
2. Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia.
Campbell JA; Ahmad H; Chen G; van der Mei I; Taylor BV; Claflin S; Henson GJ; Simpson-Yap S; Laslett LL; Hawkes K; Hurst C; Waugh H; Palmer AJ
Qual Life Res; 2023 Feb; 32(2):553-568. PubMed ID: 36036311
[TBL] [Abstract][Full Text] [Related]
3. Does health-related quality of life differ between people with relapse onset and progressive onset Multiple Sclerosis?
Ahmad H; van der Mei I; Taylor B; Zhao T; Xia Q; Palmer AJ
Mult Scler Relat Disord; 2021 Sep; 54():103138. PubMed ID: 34274737
[TBL] [Abstract][Full Text] [Related]
4. Assessing health state utilities for people with myalgic encephalomyelitis/chronic fatigue syndrome in Australia using the EQ-5D-5L, AQoL-8D and EQ-5D-5L-psychosocial instruments.
Orji NC; Cox IA; Jason LA; Chen G; Zhao T; Rogerson MJ; Kelly RM; Wills K; Hensher M; Palmer AJ; de Graaff B; Campbell JA
Qual Life Res; 2024 Jan; 33(1):45-57. PubMed ID: 37561337
[TBL] [Abstract][Full Text] [Related]
5. Measuring the health-related quality of life in Australians with multiple sclerosis using the assessment of quality of life-8-dimension (AQoL-8D) multi-attribute utility instrument.
Ahmad H; van der Mei I; Taylor BV; Campbell JA; Palmer AJ
Mult Scler Relat Disord; 2020 Sep; 44():102358. PubMed ID: 32650122
[TBL] [Abstract][Full Text] [Related]
6. Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models.
Ahmad H; Campbell JA; van der Mei I; Taylor BV; Xia Q; Zhao T; Palmer AJ
Qual Life Res; 2023 Dec; 32(12):3373-3387. PubMed ID: 37522942
[TBL] [Abstract][Full Text] [Related]
7. Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.
Claflin S; Campbell JA; Norman R; Mason DF; Kalincik T; Simpson-Yap S; Butzkueven H; Carroll WM; Palmer AJ; Blizzard CL; van der Mei I; Henson GJ; Taylor BV
Eur J Health Econ; 2023 Aug; 24(6):939-950. PubMed ID: 36149605
[TBL] [Abstract][Full Text] [Related]
8. Using qualitative free-text data to investigate the lived experience of the COVID-19 pandemic for a large cohort of Australians with different multiple sclerosis related disability levels.
Campbell JA; van der Mei I; Taylor BV; Palmer AJ; Henson GJ; Laslett LL; Simpson-Yap S; Claflin SB
J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):975-983. PubMed ID: 37884346
[TBL] [Abstract][Full Text] [Related]
9. Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review.
Zarghami A; Hussain MA; Campbell JA; Ezegbe C; van der Mei I; Taylor BV; Claflin SB
Mult Scler Relat Disord; 2022 Mar; 59():103562. PubMed ID: 35149393
[TBL] [Abstract][Full Text] [Related]
10. Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience?
Capuano R; Altieri M; Bisecco A; d'Ambrosio A; Docimo R; Buonanno D; Matrone F; Giuliano F; Tedeschi G; Santangelo G; Gallo A
J Neurol; 2021 Mar; 268(3):743-750. PubMed ID: 32725312
[TBL] [Abstract][Full Text] [Related]
11. Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis.
Lo LMP; Taylor BV; Winzenberg T; Palmer AJ; Blizzard L; Ahmad H; Hussain MA; van der Mei I
J Neurol; 2021 Feb; 268(2):569-581. PubMed ID: 32880072
[TBL] [Abstract][Full Text] [Related]
12. Chronic pain in multiple sclerosis: A 10-year longitudinal study.
Young J; Amatya B; Galea MP; Khan F
Scand J Pain; 2017 Jul; 16():198-203. PubMed ID: 28850402
[TBL] [Abstract][Full Text] [Related]
13. Higher diet quality is associated with short and long-term benefits on SF-6D health state utilities: a 5-year cohort study in an international sample of people with multiple sclerosis.
Kirkland H; Campbell J; Reece J; Nag N; Probst Y; Neate S; De Livera A; Jelinek G; Simpson-Yap S
Qual Life Res; 2023 Jul; 32(7):1883-1896. PubMed ID: 36821020
[TBL] [Abstract][Full Text] [Related]
14. SF-6D health state utilities for lifestyle, sociodemographic and clinical characteristics of a large international cohort of people with multiple sclerosis.
Campbell JA; Jelinek GA; Weiland TJ; Nag N; Neate SL; Palmer AJ; Mulhern B; De Livera A; Simpson-Yap S
Qual Life Res; 2020 Sep; 29(9):2509-2527. PubMed ID: 32488685
[TBL] [Abstract][Full Text] [Related]
15. Frequency and characteristics of falls in people living with and without multiple sclerosis during the COVID-19 pandemic: A cross-sectional online survey.
Zanotto T; Frechette ML; Koziel SR; Hsieh KL; Sosnoff JJ
Mult Scler Relat Disord; 2021 Sep; 54():103111. PubMed ID: 34303279
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 on Physical Activity Among 10,000 Steps Members and Engagement With the Program in Australia: Prospective Study.
To QG; Duncan MJ; Van Itallie A; Vandelanotte C
J Med Internet Res; 2021 Jan; 23(1):e23946. PubMed ID: 33449907
[TBL] [Abstract][Full Text] [Related]
17. Trajectories of depression and anxiety symptoms during the COVID-19 pandemic in a representative Australian adult cohort.
Batterham PJ; Calear AL; McCallum SM; Morse AR; Banfield M; Farrer LM; Gulliver A; Cherbuin N; Rodney Harris RM; Shou Y; Dawel A
Med J Aust; 2021 Jun; 214(10):462-468. PubMed ID: 33899939
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.
Dieng M; Kasparian NA; Cust AE; Costa DSJ; Tran A; Butow PN; Menzies SW; Mann GJ; Morton RL
JAMA Dermatol; 2018 Jan; 154(1):52-59. PubMed ID: 29188268
[TBL] [Abstract][Full Text] [Related]
19. The cancer patient's perspective of COVID-19-induced distress-A cross-sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic.
Koinig KA; Arnold C; Lehmann J; Giesinger J; Köck S; Willenbacher W; Weger R; Holzner B; Ganswindt U; Wolf D; Stauder R
Cancer Med; 2021 Jun; 10(12):3928-3937. PubMed ID: 33973411
[TBL] [Abstract][Full Text] [Related]
20. The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument.
Zheng Q; Cox IA; de Graaff B; Campbell JA; Corte TJ; Glaspole I; Navaratnam V; Hopkins P; Zappala C; Ahmad H; Zhao T; Macansh S; Walters EH; Palmer AJ
Qual Life Res; 2023 Jun; 32(6):1609-1619. PubMed ID: 36572788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
